Abstract

quinine oxidoreductase 1 (NQO1), and potent degradation of Tat is induced by dicoumarol, an NQO1 inhibitor. Furthermore, Rev causes specific reduction in the levels of endogenous NQO1. Thus, we propose that Rev is able to induce degradation of Tat indirectly by downregulating NQO1 levels. Our findings have implications in HIV-1 gene expression and latency.

Highlights

  • HIV-1 gene expression and replication largely depend on the regulatory proteins Tat and Rev, but it is unclear how the intracellular levels of these viral proteins are regulated after infection

  • By a series of experiments we show that Rev leads to marked reduction in HIV-1 gene expression, which correlated with the decrease in intracellular levels of Tat

  • HIV-1 latency arises when the intracellular levels of the regulatory protein Tat falls below a critical threshold level

Read more

Summary

Introduction

HIV-1 gene expression and replication largely depend on the regulatory proteins Tat and Rev, but it is unclear how the intracellular levels of these viral proteins are regulated after infection. Tat and Rev proteins are able to shuttle between the nucleus and cytoplasm and potentially perform functions in both of these cellular compartments[6,7,8,9] Both Tat and Rev extensively exploit various cellular factors to govern viral gene expression[10,11]. We observed that NQO1 stabilizes Tat protein in a dose-dependent manner and the inhibitor of NQO1, dicoumarol, potently induces degradation of the Tat protein and inhibits HIV-1 replication. Rev downmodulates the expression of NQO1 in a dose-dependent manner These observations have very significant implications with respect to controlling HIV-1 gene expression and latency

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.